Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Renaissance Global Health Care Fund Class A
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade C
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
NAVPS (05-13-2026) |
$49.48 |
|---|---|
| Change |
$0.21
(0.43%)
|
As at April 30, 2026
As at April 30, 2026
As at April 30, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (November 02, 1996): 10.82%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -1.84% | -6.97% | -1.39% | -6.55% | 14.08% | 9.51% | 5.20% | 5.79% | 4.22% | 4.12% | 5.70% | 6.44% | 4.90% | 5.95% |
| Benchmark | -2.20% | -5.11% | -0.92% | -4.87% | 5.78% | 3.80% | 4.47% | 5.87% | 5.46% | 5.98% | 7.70% | 8.37% | 7.92% | 8.80% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 20 / 53 | 31 / 51 | 19 / 51 | 25 / 51 | 4 / 51 | 4 / 49 | 6 / 43 | 8 / 41 | 15 / 39 | 19 / 36 | 18 / 35 | 17 / 32 | 19 / 29 | 17 / 29 |
| Quartile Ranking | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
Monthly Return
| Return % | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -6.21% | 1.55% | 1.84% | 2.31% | 2.18% | 14.10% | 7.21% | -1.57% | 0.45% | 2.11% | -7.19% | -1.84% |
| Benchmark | -3.48% | 0.91% | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% |
Best Monthly Return Since Inception
19.43% (February 2000)
Worst Monthly Return Since Inception
-11.14% (February 2009)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -13.43% | 5.31% | 6.67% | 16.38% | 9.15% | 8.24% | -6.70% | -2.51% | 11.04% | 18.39% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 2 | 4 | 3 | 2 | 3 | 4 | 3 | 4 | 1 | 1 |
| Category Rank | 13/ 29 | 29/ 29 | 17/ 32 | 17/ 34 | 26/ 35 | 30/ 38 | 27/ 40 | 38/ 41 | 10/ 48 | 3/ 50 |
Best Calendar Return (Last 10 years)
18.39% (2025)
Worst Calendar Return (Last 10 years)
-13.43% (2016)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 60.48 |
| International Equity | 36.13 |
| Cash and Equivalents | 3.40 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 95.17 |
| Cash and Cash Equivalent | 3.40 |
| Consumer Services | 1.44 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 63.84 |
| Europe | 35.50 |
| Asia | 0.66 |
Top Holdings
| Name | Percent |
|---|---|
| Eli Lilly and Co | 10.09 |
| Johnson & Johnson | 9.03 |
| UnitedHealth Group Inc | 8.47 |
| Roche Holding AG | 8.02 |
| Thermo Fisher Scientific Inc | 7.77 |
| Medtronic PLC | 6.82 |
| Novartis AG Cl N | 6.52 |
| Abbvie Inc | 6.44 |
| AstraZeneca PLC | 5.31 |
| Amgen Inc | 4.99 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Renaissance Global Health Care Fund Class A
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 15.49% | 14.33% | 13.51% |
|---|---|---|---|
| Beta | 1.15 | 1.07 | 1.06 |
| Alpha | 0.00 | -0.01 | -0.03 |
| Rsquared | 0.71% | 0.77% | 0.84% |
| Sharpe | 0.17 | 0.16 | 0.35 |
| Sortino | 0.35 | 0.23 | 0.43 |
| Treynor | 0.02 | 0.02 | 0.05 |
| Tax Efficiency | 68.60% | 59.19% | 79.80% |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 19.51% | 15.49% | 14.33% | 13.51% |
| Beta | 1.19 | 1.15 | 1.07 | 1.06 |
| Alpha | 0.07 | 0.00 | -0.01 | -0.03 |
| Rsquared | 0.64% | 0.71% | 0.77% | 0.84% |
| Sharpe | 0.64 | 0.17 | 0.16 | 0.35 |
| Sortino | 1.17 | 0.35 | 0.23 | 0.43 |
| Treynor | 0.11 | 0.02 | 0.02 | 0.05 |
| Tax Efficiency | 77.99% | 68.60% | 59.19% | 79.80% |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | November 02, 1996 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $661 |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| ATL1161 | ||
| ATL1162 | ||
| ATL2162 |
Investment Objectives
To obtain long-term capital appreciation by investing primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded on a U.S. exchange, which are engaged in the design, development, manufacturing, and distribution of products or services in the health care sectors. The Fund will invest in a diversified portfolio, which will mainly include securities in the medical technology, biotechnology, health care, and pharmaceutical sectors
Investment Strategy
To achieve its investment objectives, the Fund: within each sub-sector of health care, identify attractive investment opportunities through bottom-up stock selection that is driven by the fundamental understanding of the science and technology behind a prospective company’s products and services; may invest in U.S. companies; may invest in companies from around the world (global companies), that may be listed on U.S. exchanges or other major exchanges around the world.
Portfolio Management
| Portfolio Manager |
CIBC Asset Management Inc.
|
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
CIBC Asset Management Inc. |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
CIBC Asset Management Inc. |
| Distributor |
- |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 500 |
| PAC Subsequent | 50 |
| SWP Allowed | Yes |
| SWP Min Balance | 10,000 |
| SWP Min Withdrawal | 50 |
Fees
| MER | 2.50% |
|---|---|
| Management Fee | 2.10% |
| Load | Choice of Front or No Load |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | 1.00% |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
